A multicentre comparison of once‐daily subcutaneous dalteparin (low molecular weight heparin) and continuous intravenous heparin in the treatment of deep vein thrombosis - Concepedia

Concepedia

Publication | Closed Access

A multicentre comparison of once‐daily subcutaneous dalteparin (low molecular weight heparin) and continuous intravenous heparin in the treatment of deep vein thrombosis

89

Citations

0

References

1996

Year

K Luomanmäki, S. GRANKVIST, Claes Hallert, I. JAURO, K. KETOLA, H. C. KIM, Heikki Kiviniemi, H. KOSKIVIRTA, L. SÖRSKOG, Pekka Vilkko

Journal of Internal Medicine

Abstract

Fixed-dose subcutaneous dalteparin given once daily from the start of treatment is of equivalent efficacy and safety to conventional UFH therapy in the routine management of DVT.